Ethnic Differences in Mechanisms of Action of Dupilumab

NCT05268107 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Dupilumab

Sponsor

University of Michigan

Collaborators

[object Object]